AI is not the villain here; it is a mirror,” reflecting the diminishment of physician judgment, writes former surgeon Frances ...
It was briefly more dangerous to sit at a desk in Atlanta than to chase a hemorrhagic fever in the field,” writes Daniel ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The National Institutes of Health plans to close the door on one of ...
Coller is Bloomberg distinguished professor of RNA biology and therapeutics at Johns Hopkins University and a co-founder of the Alliance for mRNA Medicines. On Wednesday, the Food and Drug ...
Noel T. Brewer and colleagues will soon decide whether the U.S. has maintained its elimination status. Here’s what they’re ...
The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a ...
The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can ...
That’s the case with a new study in Nature Medicine titled, “Is AI actually improving healthcare?” Yes, it is. This much we ...
The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.
With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: ...
Pre-biopsy MRI is standard outside the U.S., but the latest data show such scans were done in only about a third of U.S.
Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results